Novartis Shareholders Approve Dividend Raise, Share Capital Reduction
Published on 03/06/2026 at 10:26 am EST
MT Newswires
Share
Share
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 117.54 CHF | -0.68% |
|
-3.50% | +7.57% |
| Apr. 15 | Novartis CEO joins Anthropic board of directors |  |
| Apr. 15 | Swiss stocks - Factors to watch on April 15 | RE |
![Giovanni Caforio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Currently, Giovanni Caforio occupies the position of Chairman & Chief Executive Officer for Bristol Myers Squibb Co. Dr. Caforio is also on the board of Stryker Corp., European Federation of Pharmaceutical Industries & Assns and Hun School of Princeton, Inc. and Member of The Business Roundtable and Member of TJ Holdings LLC. In the past Dr. Caforio held the position of General Manager of Abbott Laboratórios Lda., Co-Chairman of Pharmaceutical Research & Manufacturers of America and Member of CEO Roundtable on Cancer, Inc. He received a doctorate from Università degli Studi di Roma Tor Vergata.
Employees
75,267
Sector
Pharmaceuticals
Calendar
Apr. 28 -
Earnings release - Q1 2026
Trader
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
AAA
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
151.50USD
Average target price
153.89USD
Spread / Average Target
+1.57%
Quarterly revenue - Rate of surprise
- Stock Market
- Stock Market News
- Novartis Shareholders Approve Dividend Raise, Share Capital Reduction
Select your edition
All financial news and data tailored to specific country editions
